Under the restriction order of antibiotics usage, many antibiotics have been listed in the scope of “restricted drugs” and “special drugs”, and the market development has been subject to large restrictions, with sales shrinking and market reshuffled.
Antibiotics used to treat a variety of common bacterial infections are becoming more difficult to access, mostly because the drugs are less profitable for manufacturers to produce and market.